Pharma In The Crosshairs: Dual Drug Pricing Hearings Portend Rocky Road Ahead – And Potential Subpoenas

 
• By Kate Rawson
Pill in crosshairs
Several congressional panels might hold drug pricing hearings in the coming weeks.

More from Legislation

More from Pink Sheet